Cemdisiran (sodium)
Product Sizes
10 mg
£ POA
HY-145720A-10MG
1 mg
£ POA
HY-145720A-1MG
5 mg
£ POA
HY-145720A-5MG
25 mg
£ POA
HY-145720A-25MG
About this Product
- SKU:
- HY-145720A
- Additional Names:
- ALN-CC5 (sodium)
- Extra Details:
- Cemdisiran sodium is an N-acetylgalactosamine (GalNAc) conjugated siRNA for the research of complement-mediated diseases by suppressing liver production of complement 5 (C5) protein.
- Molecular Weight:
- 16782.66 (free acid)
- Purity:
- 96.30
- References:
- [1]Badri P, Jiang X, Borodovsky A, et al. Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria. Clin Pharmacokinet. 2021;60(3):365-378.|[2]Prajakta Badri, et al. Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria. Clin Pharmacokinet. 2021;60(3):365-378.
- Research Area:
- Others
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; sealed storage; away from moisture)
- Type:
- Molecular Biology Reagents: Nucleic Acids
- Pathway:
- Immunology/Inflammation
